PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-34.77%
Negative revenue growth while 8198.HK stands at 8.61%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-21.03%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-10.81%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
16.51%
Positive net income growth while 8198.HK is negative. John Neff might see a big relative performance advantage.
16.56%
Positive EPS growth while 8198.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
16.56%
Positive diluted EPS growth while 8198.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 8198.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.43%
Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-22.18%
Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-32.72%
Negative 10Y revenue/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.73%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-41.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
332.45%
OCF/share CAGR of 332.45% while 8198.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
15.73%
Below 50% of 8198.HK's 85.88%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
156.34%
3Y OCF/share CAGR above 1.5x 8198.HK's 76.03%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-25.84%
Negative 10Y net income/share CAGR while 8198.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-34.73%
Negative 5Y net income/share CAGR while 8198.HK is 91.24%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
8.33%
Below 50% of 8198.HK's 94.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
40.38%
Below 50% of 8198.HK's 138.25%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.50%
Below 50% of 8198.HK's 115.89%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-54.66%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-21.05%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
17.16%
Inventory growth of 17.16% while 8198.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-21.04%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.20%
BV/share growth of 2.20% while 8198.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-38.98%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-23.61%
We cut SG&A while 8198.HK invests at 5.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.